These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17229170)

  • 1. How to lose a billion pounds.
    Moon JC; Bogle RG
    Int J Clin Pract; 2007 Jan; 61(1):2-3. PubMed ID: 17229170
    [No Abstract]   [Full Text] [Related]  

  • 2. Getting better value from the NHS drug budget.
    Moon JC; Flett AS; Godman BB; Grosso AM; Wierzbicki AS
    BMJ; 2010 Dec; 341():c6449. PubMed ID: 21169320
    [No Abstract]   [Full Text] [Related]  

  • 3. Zero copayment for generic statins could save billions.
    Manag Care; 2013 Mar; 22(3):44. PubMed ID: 23610806
    [No Abstract]   [Full Text] [Related]  

  • 4. Statin utilisation--recognising the role of the invisible hand.
    Minhas R
    Int J Clin Pract; 2007 Jan; 61(1):3-6. PubMed ID: 17229171
    [No Abstract]   [Full Text] [Related]  

  • 5. Generic atorvastatin and health care costs.
    Kennally WC
    N Engl J Med; 2012 Apr; 366(15):1451; author reply 1451. PubMed ID: 22494136
    [No Abstract]   [Full Text] [Related]  

  • 6. Encouraging generic use can yield significant savings.
    Zimmerman C
    Find Brief; 2012 Nov; 15(8):1-3. PubMed ID: 23213854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic atorvastatin and health care costs.
    Jackevicius CA; Chou MM; Ross JS; Shah ND; Krumholz HM
    N Engl J Med; 2012 Jan; 366(3):201-4. PubMed ID: 22149736
    [No Abstract]   [Full Text] [Related]  

  • 8. The cost of prescription drugs: a comparison of two countries.
    Jick H; Wilson A
    Pharmacotherapy; 2012 Nov; 32(11):967-9. PubMed ID: 23124721
    [No Abstract]   [Full Text] [Related]  

  • 9. Are intensive lipid-lowering regimens an optimal economic strategy in patients with ACS? An acute and chronic perspective.
    Ara R; Rafia R; Ward SE; Wierzbicki AS; Reynolds TM; Rees A; Pandor A
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):423-33. PubMed ID: 19817526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia.
    Simoens SR
    Med J Aust; 2011 Jan; 194(1):52-3; author reply 53-4. PubMed ID: 21449876
    [No Abstract]   [Full Text] [Related]  

  • 11. Rates and pillage.
    Moore A
    Health Serv J; 2002 Dec; 112(5834):10-1. PubMed ID: 12500593
    [No Abstract]   [Full Text] [Related]  

  • 12. Switching statins: cost of simvastatin is overestimated.
    Ashcroft JS
    BMJ; 2006 Jun; 332(7556):1512. PubMed ID: 16793831
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study.
    Heinze G; Hronsky M; Reichardt B; Baumgärtel C; Müllner M; Bucsics A; Winkelmayer WC
    Appl Health Econ Health Policy; 2015 Apr; 13(2):193-205. PubMed ID: 25536928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential impact of policy regulation and generic competition on sales of cholesterol lowering medication, antidepressants and acid blocking agents in Belgium.
    Fraeyman J; Van Hal G; De Loof H; Remmen R; De Meyer GR; Beutels P
    Acta Clin Belg; 2012; 67(3):160-71. PubMed ID: 22897063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions.
    Hoadley JF; Merrell K; Hargrave E; Summer L
    Health Aff (Millwood); 2012 Oct; 31(10):2266-75. PubMed ID: 23048108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug use review matters.
    Mueting M
    Nebr Nurse; 2007; 40(3):28. PubMed ID: 17915614
    [No Abstract]   [Full Text] [Related]  

  • 17. Switching statins.
    Moon JC; Bogle RG
    BMJ; 2006 Jun; 332(7554):1344-5. PubMed ID: 16763226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug costs. Cost a packet.
    Davies J
    Health Serv J; 2000 Mar; 110(5698):suppl 11-2. PubMed ID: 11183710
    [No Abstract]   [Full Text] [Related]  

  • 19. The pricing of statins and implications for Pharmaceutical Benefits Scheme expenditure.
    Clarke PM
    Med J Aust; 2013 Mar; 198(5):260. PubMed ID: 23496399
    [No Abstract]   [Full Text] [Related]  

  • 20. Generic substitution of drugs to be introduced in 2010.
    Jack A
    BMJ; 2008 Nov; 337():a2699. PubMed ID: 19029178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.